Published • loading... • Updated
Multiple Sclerosis: a Revolutionary New Treatment that Will Soon Be Available in France?
Summary by NotreTemps.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A green light that could change the lives of patients with multiple sclerosis? This is in any case a first step that raises the hope of some patients and caregivers. A new treatment, tolebrutinib (commercialized under the name Cenrifki), has just obtained a first positive opinion in Europe, indispensable prerequisite before a possible arrival in France. What can be expected of this new treatment? When could French patients have access to it? We …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
